| 摘要 |
FIELD: medicine.SUBSTANCE: invention relates to medicine, in particular, to allergology and immunology, and deals with treatment of patients with autoimmune chronic urticaria. For this purpose native immunoglobulin Gabreglobine is introduced in dose 50 ml one time for 4 days.EFFECT: method ensures increase of treatment efficiency, reduction of frequency of exacerbations and reduction of dose of antihistamine medications due to introduction of immunoglobulin, characterised by the greatest content of monomer immunoglobulin G with preserved Fc-fragment, complete absence of aggregates and distribution of antibodies, as well as corresponding to territorial peculiarities, in empirically selected dose and introduction mode.1 tbl, 2 ex |
